Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

56.32
Delayed Data
As of Oct 20
 +0.32 / +0.57%
Today’s Change
37.38
Today|||52-Week Range
56.60
+46.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues5.3B6.3B6.6B6.8B
 
 
 
 
 
Cost of Goods Sold2.1B2.8B2.9B2.9B
 
 
 
 
 
Depreciation And Amortization319.0M774.0M648.0M--
 
 
 
 
 
Operating ExpensesGross Income2.9B2.8B3.1B4.0B
 
 
 
 
 
General Expenses2.0B2.8B2.6B2.7B
 
 
 
 
 
Other Operating Expenses0.000.000.00501.0M
 
 
Research And Development343.0M541.0M512.0M562.0M
 
 
 
 
 
Total Operating Expenses4.4B6.4B6.2B6.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income965.0M-66.0M455.0M810.0M
 
 
 
 
 
Extraordinary Charge-6.0M-131.0M-26.0M--
 
 
 
 
Interest Expense On Debt159.0M207.0M181.0M182.0M
 
 
 
 
 
Other Expenses45.0M1.1B9.0M-2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income875.0M736.0M295.0M626.0M
 
 
 
 
 
Income Taxes-110.0M-350.0M-25.0M-65.0M
 
 
 
 
 
Discontinued Operations33.0M33.0M13.0M42.0M
 
 
 
 
 
Net Income793.0M417.0M282.0M603.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5B1.7B1.7B--
 
 
 
 
Shares To Calculate EPS Diluted1.5B1.7B1.7B1.8B
 
 
 
 
 
 
Earnings Per ShareEPS$0.53$0.24$0.16$0.34
 
 
 
 
 
EPS Diluted$0.54$0.24$0.16$0.34